Skip to main content
Top
Literature
2.
go back to reference Gralnek IM, Stanley AJ, Morris AJ et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2021. Endoscopy 2021;53:300–332.CrossRefPubMed Gralnek IM, Stanley AJ, Morris AJ et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2021. Endoscopy 2021;53:300–332.CrossRefPubMed
3.
go back to reference Laine L, Barkun AN, Saltzman JR et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol 2021;116:899–917.CrossRefPubMed Laine L, Barkun AN, Saltzman JR et al. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol 2021;116:899–917.CrossRefPubMed
4.
go back to reference Guven IE, Baspinar B, Durak MB et al. Comparison of urgent and early endoscopy for acute non-variceal upper gastrointestinal bleeding in high-risk patients. Gastroenterol Hepatol 2023;46:178–184.CrossRefPubMed Guven IE, Baspinar B, Durak MB et al. Comparison of urgent and early endoscopy for acute non-variceal upper gastrointestinal bleeding in high-risk patients. Gastroenterol Hepatol 2023;46:178–184.CrossRefPubMed
5.
go back to reference Durak MB, Simsek C, Yuksel I. Clinical outcomes of older patients with non-variceal upper gastrointestinal bleeding taking anti-thrombotic or non-steroidal anti-inflammatory agents. Turk J Gastroenterol 2023;34:918–924.PubMed Durak MB, Simsek C, Yuksel I. Clinical outcomes of older patients with non-variceal upper gastrointestinal bleeding taking anti-thrombotic or non-steroidal anti-inflammatory agents. Turk J Gastroenterol 2023;34:918–924.PubMed
6.
go back to reference Scally B, Emberson JR, Spata E et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. Lancet Gastroenterol Hepatol 2018;3:231–241.CrossRefPubMedPubMedCentral Scally B, Emberson JR, Spata E et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials. Lancet Gastroenterol Hepatol 2018;3:231–241.CrossRefPubMedPubMedCentral
7.
go back to reference Stanley AJ, Laine L, Dalton HR et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ 2017;356:i6432.CrossRefPubMedPubMedCentral Stanley AJ, Laine L, Dalton HR et al. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ 2017;356:i6432.CrossRefPubMedPubMedCentral
8.
go back to reference Yamaguchi D, Sakata Y, Tsuruoka N et al. Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents. Dig Endosc 2015;27:30–36.CrossRefPubMed Yamaguchi D, Sakata Y, Tsuruoka N et al. Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents. Dig Endosc 2015;27:30–36.CrossRefPubMed
Metadata
Title
Optimal Timing of Endoscopy in Patients Taking Anticoagulants with Upper Gastrointestinal Bleeding
Author
Muhammed Bahaddin Durak
Publication date
07-05-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08397-7
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.